Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWO
1976
Two Harbors Investment
TWO
$1.27B
| $4.44M | ﹤0.01% |
220,394
+33,383
| +18% | +$620K |
|
1977
Regenxbio
RGNX
$708M
| $4.41M | ﹤0.01% |
119,808
-274,900
| -70% | -$10.2M |
|
1978
Genuine Parts
GPC
$18.7B
| $4.4M | ﹤0.01% |
50,640
-67,692
| -57% | -$5.35M |
|
1979
United Natural Foods
UNFI
$2.85B
| $4.39M | ﹤0.01% |
+241,000
| New | +$3.61M |
|
1980
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $4.38M | ﹤0.01% |
112,000
-7,480
| -6% | -$265K |
|
1981
Waters Corp
WAT
$39.9B
| $4.38M | ﹤0.01% |
24,265
-8,350
| -26% | -$1.58M |
|
|
TECD
1982
DELISTED
Tech Data Corp
TECD
| $4.37M | ﹤0.01% |
30,153
+29,630
| +5,665% | +$4.1M |
|
1983
Natural Gas Services Group
NGS
$477M
| $4.36M | ﹤0.01% |
695,319
-45,040
| -6% | -$261K |
|
1984
Core Molding Technologies
CMT
$234M
| $4.36M | ﹤0.01% |
1,057,295
+4,944
| +0.5% | +$15.9K |
|
1985
Molson Coors Class B
TAP
$8.09B
| $4.36M | ﹤0.01% |
126,762
-163,824
| -56% | -$6.54M |
|
|
PRFT
1986
DELISTED
Perficient Inc
PRFT
| $4.34M | ﹤0.01% |
121,277
-17,244
| -12% | -$572K |
|
1987
Viridian Therapeutics
VRDN
$2.67B
| $4.32M | ﹤0.01% |
259,244
| – | – |
|
1988
Shenandoah Telecom
SHEN
$746M
| $4.29M | ﹤0.01% |
86,963
-2,200
| -2% | -$112K |
|
1989
Quanta Services
PWR
$101B
| $4.28M | ﹤0.01% |
109,206
-17,134
| -14% | -$611K |
|
1990
Credit Acceptance
CACC
$6.08B
| $4.28M | ﹤0.01% |
10,218
+307
| +3% | +$107K |
|
1991
Fidelity National Financial
FNF
$13.5B
| $4.26M | ﹤0.01% |
144,591
-2,868,447
| -95% | -$78.9M |
|
1992
Corcept Therapeutics
CORT
$12B
| $4.23M | ﹤0.01% |
251,260
-249,807
| -50% | -$3.51M |
|
1993
Vanguard Health Care ETF
VHT
$18.7B
| $4.22M | ﹤0.01% |
21,894
+5,615
| +34% | +$1.05M |
|
1994
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $4.19M | ﹤0.01% |
1,232,208
+3,019
| +0.2% | +$9.52K |
|
|
DNR
1995
DELISTED
Denbury Resources, Inc.
DNR
| $4.17M | ﹤0.01% |
15,085,566
-484,984
| -3% | -$146K |
|
1996
Helmerich & Payne
HP
$3.71B
| $4.1M | ﹤0.01% |
210,325
-233,428
| -53% | -$4.55M |
|
|
TEF
1997
DELISTED
Telefonica
TEF
| $4.09M | ﹤0.01% |
1,009,218
-275
| -0% | -$1.06K |
|
1998
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.17B
| $4.08M | ﹤0.01% |
149,309
+78,501
| +111% | +$2.11M |
|
1999
Essential Properties Realty Trust
EPRT
$6.62B
| $4.06M | ﹤0.01% |
273,891
-1,321,657
| -83% | -$18.2M |
|
2000
Cooper-Standard Automotive
CPS
$558M
| $4.04M | ﹤0.01% |
305,217
+200,217
| +191% | +$2.43M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.